Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket

INVO Bioscience, Inc. INVO shares surged in pre-market trading after the company posted a narrower loss for the third quarter.

INVO Bioscience posted quarterly loss of 70 cents per share, versus a year-ago loss of $4.19 per share. The company’s quarterly sales surged 314% year-over-year to $974,894.

INVO Bioscience shares climbed 31.1% to $2.11 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Alaunos Therapeutics, Inc. TCRT shares rose 62.9% to $0.1354 in pre-market trading after falling 12% on Monday.
• reAlpha Tech Corp. AIRE shares surged 57.8% to $9.30 in pre-market trading after jumping around 34% on Monday.
• Hanryu Holdings, Inc. HRYU shares rose 40.2% to $1.36 in pre-market trading after falling 3% on Monday.
• Theseus Pharmaceuticals, Inc. THRX shares rose 24.3% to $2.66 in pre-market trading after the company announced process to explore strategic alternatives.
• RedHill Biopharma Ltd. RDHL rose 15.3% to $0.3574 in pre-market trading.
• Absci Corporation ABSI rose 14.4% to $1.43 in pre-market trading. Almirall and Absci disclosed AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases.
• PaxMedica, Inc. PXMD gained 12.3% to $1.92 in pre-market trading. The company recently announced research findings in the Annals of General Psychiatry regarding a study on low-dose suramin intravenous infusions as a potential treatment for Autism Spectrum Disorder.
• Advent Technologies Holdings, Inc. ADN shares rose 11.8% to $0.4848 in pre-market trading.
• Singular Genomics Systems, Inc. OMIC gained 11.4% to $0.39 in pre-market trading. Singular Genomics Systems is expected to report financial results for the third quarter 2023 after the closing bell on Nov. 14, 2023.

Losers

• The Beauty Health Company SKIN dipped 51.7% to $1.88 in pre-market trading after the company reported weaker-than-expected financial results for its third quarter and revised its net sales outlook. Also, the company suspended its long-term full-year 2025 forecast.
• Harrow, Inc. HROW shares fell 24.6% to $9.67 in pre-market trading as the company reported downbeat third-quarter financial results and lowered its revenue guidance.
• Applied UV, Inc. AUVI shares fell 22.6% to $0.2090 in pre-market trading after reporting selected preliminary financial results for the third quarter.
• Akili, Inc. AKLI shares fell 21.4% to $0.3531 in pre-market trading. The company recently posted a narrower-than-expected quarterly loss.
• HeartCore Enterprises, Inc. HTCR fell 16.3% to $0.4350 in pre-market. HeartCore recently posted downbeat third-quarter sales.
• Peraso Inc. PRSO shares fell 14.7% to $0.2038 in pre-market trading after the company announced third-quarter results.
• Fisker Inc. FSR shares fell 13.4% to $3.56 in pre-market trading following third-quarter results.
• TRACON Pharmaceuticals, Inc. TCON fell 13.1% to $0.1859 in pre-market trading after declining around 7% on Monday. TRACON Pharma recently posted a profit for the third quarter.
• Tenax Therapeutics, Inc. TENX fell 10.9% to $0.5527 in pre-market trading. Tenax Therapeutics shares jumped 297% on Monday morning after the company received FDA clearance of the IND for TNX-103, an oral levosimendan, to treat pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF).
• Beyond Air, Inc. XAIR shares fell 10.3% to $1.82 in pre-market trading following weak quarterly results.

Now Read This: Home Depot Likely To Report Lower Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call